Evidence map›Paper›PMID 27421843›Full record

ArticleVirchows Archiv : an international journal of pathology2016

HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.

Anne Tuomisto, José García-Solano, Päivi Sirniö, Juha Väyrynen, Miguel Pérez-Guillermo, Markus J Mäkinen, Pablo Conesa-Zamora

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Anne TuomistoCancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, POB 5000, 90014, Oulu, Finland. anne.tuomisto@oulu.fi.
José García-SolanoDepartment of Pathology, Santa Lucía University Hospital, C/Mezquita sn, 30202, Cartagena, Spain.
Päivi SirniöCancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, POB 5000, 90014, Oulu, Finland.
Juha VäyrynenCancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, POB 5000, 90014, Oulu, Finland.
Miguel Pérez-GuillermoDepartment of Pathology, Santa Lucía University Hospital, C/Mezquita sn, 30202, Cartagena, Spain.
Markus J MäkinenCancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, POB 5000, 90014, Oulu, Finland.
Pablo Conesa-ZamoraDepartment of Pathology, Santa Lucía University Hospital, C/Mezquita sn, 30202, Cartagena, Spain. Pablo.conesa@carm.es.
University of Oulu · FISanta Lucía University General Hospital · ESOulu University Hospital · FIUniversidad de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia-independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α-mediated pathways for the serrated route of colorectal carcinogenesis.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryMaleMicrovesselsMiddle AgedNeovascularization, PathologicVascular Endothelial Growth Factor AHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor AColorectal cancerHIF-1Microvessel densitySerrated adenocarcinoma

Identifiers

PMID27421843
OpenAlexW2464630435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.